Patents by Inventor Fei Shen

Fei Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12276488
    Abstract: A multi-compartment mortar increment container (MIC) enables burning of two propellants to broaden the pressure-time curve providing additional energy and force behind a mortar shell while maintaining allowable pressures. During the ballistic cycle, the mortar increment container burns allowing the faster propellant to mix with the slower propellant. The slower propellant will burn later in the ballistic cycle generating higher pressure behind the projectile leading to higher velocity.
    Type: Grant
    Filed: September 20, 2023
    Date of Patent: April 15, 2025
    Assignee: The United States of America as Represented by the Secretary of the Army
    Inventors: Viral Panchal, Linjie Zhu, Fei Shen, Mingwan Young, Jacqueline A. Longcore, Dylan McHugh, Chandrark Patel, Elbert Caravaca, Mohamed Elalem
  • Publication number: 20250109428
    Abstract: In some examples, a hybrid particle for use in capturing a polynucleotide may include a scaffold molecule including a seeding primer and a plurality of first moieties, and a nanoparticle including a plurality of second moieties. The scaffold molecule is coupled to the nanoparticle via interactions between the plurality of first moieties and the plurality of second moieties.
    Type: Application
    Filed: September 27, 2024
    Publication date: April 3, 2025
    Applicant: Illumina, Inc.
    Inventors: Olivia Ghazinejad, Fei Shen, Kyle Bentz, Rohit Subramanian, Eric Brustad, Lena Storms, Xiaoyu Ma, Mathieu Lessard-Viger, Jeffrey Brodin
  • Publication number: 20250099635
    Abstract: Provided herein are immunoconjugates, such as radioimmunoconjugates, comprising a therapeutic moiety conjugated to an antibody or antigen binding domain with binding specificity for hK2. In certain embodiments, the hK2-specific immunoconjugate demonstrates a short half-life. Also provided herein are methods of using the immunoconjugates for selectively targeting cancer cells and for treating diseases such as prostate cancer.
    Type: Application
    Filed: January 25, 2023
    Publication date: March 27, 2025
    Inventors: Fei SHEN, Theresa MCDEVITT, Shalom GOLDBERG, Kristen WILLEY, Ryan M. SMITH, Sathyadevi VENKATARAMANI
  • Patent number: 12258742
    Abstract: A liquid dispenser sensing distance self-learning method includes in response to a self-learning request, entering a self-learning mode. The method also includes, in the self-learning mode, determining a shortest distance between a reference object and a sensing component; determining and storing a sensing distance based on the shortest distance; and identifying, by a first indication device, a state of the self-learning mode. The method also includes, in response to a sensing request, entering a sensing mode; obtaining a detected distance between the reference object and the sensing component; comparing the detected distance with the sensing distance; and identifying, by a second indication device, a comparison result of the detected distance and the sensing distance.
    Type: Grant
    Filed: September 8, 2023
    Date of Patent: March 25, 2025
    Assignee: Shanghai Kohler Electronics, Ltd.
    Inventors: Wenjie Ren, Fei Shen
  • Publication number: 20250011862
    Abstract: In some examples, a method for capturing and amplifying a polynucleotide includes capturing the polynucleotide at a particle comprising a first region and a second region. The first region may include a first moiety that captures the polynucleotide. The second region may include a plurality of amplification primers and have a surface area which is substantially larger than the surface area of the first portion. The method includes using the plurality of amplification primers to amplify the captured polynucleotide.
    Type: Application
    Filed: June 25, 2024
    Publication date: January 9, 2025
    Applicant: Illumina, Inc.
    Inventors: Sahngki Hong, Fei Shen, Lewis Kraft
  • Publication number: 20240421538
    Abstract: The present disclosure provides a power adapter including a body and a plug removably connected to the body. In one example, the plug has a second base defining a groove, a housing, and a prong rotatably mounted to the housing. In another example, the body has a tongue extending from a first base, which slides within the groove of the plug to prevent movement of the plug in a first direction. In one example, rotation of the prong actuates a pin held within the plug. For example, the pin recedes into the second base when the prong is in a first position and protrudes from the second base when the prong is in a second position. In one example, the pin prevents movement of the plug in a second direction, different from the first direction, when the prong is in the second position.
    Type: Application
    Filed: June 15, 2023
    Publication date: December 19, 2024
    Inventors: Feng Chen, Jie Zhang, Xu-Fei Shen
  • Patent number: 12170062
    Abstract: The present disclosure relates to the field of display technology, and provides a display device and a driving method therefor. The driving method includes: providing a display device including a plurality of sub-pixels, each sub-pixel including an OLED light-emitting element, a light-emitting control transistor configured to transmit a driving current to the OLED light-emitting element, and a reset transistor coupled to an anode of the OLED light-emitting element; inputting a periodic cut-off signal to the light-emitting control transistor; determining the effective light-emitting phase of each frame period for the sub-pixel; and during the effective light-emitting phase of each frame period for the sub-pixel, inputting a reset signal to the reset transistor corresponding to one or more cut-off signal.
    Type: Grant
    Filed: June 18, 2021
    Date of Patent: December 17, 2024
    Assignee: Everdisplay Optronics (Shanghai) Co., Ltd.
    Inventors: Keitaro Yamashita, Jehyen Kang, Xiangshu Li, Fei Shen
  • Publication number: 20240410148
    Abstract: An interchangeable touchless faucet system for use with interchangeable spouts and related methods of replacing interchangeable faucets. The interchangeable faucet design generally includes coupling variations of a spout, which may be readily attached and detached to a sensor puck. Fluid is delivered through the sensor puck and through one of the interchangeable spouts from a mixer valve coupled to hot and cold waterlines, where the fluid is dispensed into a basin, sink, tub, etc. when a sensor integrated with the sensor puck is activated by a user, such as by waving one's hand near the sensor.
    Type: Application
    Filed: June 6, 2024
    Publication date: December 12, 2024
    Inventors: Tai Woon WOON, Fei SHEN, Yaohui ZHANG
  • Publication number: 20240409544
    Abstract: The disclosure provides compounds of formula (II) having the structure: Compounds of formula (II) are fractalkine receptor agonists and useful in treating, preventing or minimizing metastasis in a subject diagnosed with cancer. The compounds of the disclosure are further useful in treating central nervous system diseases (such as, but not limited to, HIV Associated Neurocognitive Disorders (HAND), and/or Alzheimer's disease), pain, inflammation (such as, but not limited to, arthritis), cardiovascular disease (such as, but not limited to, undesired vascular smooth muscle proliferation, atherosclerosis, coronary vascular endothelial dysfunction, and/or coronary artery disease), and/or multiple sclerosis.
    Type: Application
    Filed: January 2, 2024
    Publication date: December 12, 2024
    Inventors: Joseph M. Salvino, Xin Feng, Alessandro Fatatis, Fei Shen, Olimpia Meucci
  • Patent number: 12152036
    Abstract: The disclosure provides compounds of formula (II) having the structure: Compounds of formula (II) are fractalkine receptor agonists and useful in treating, preventing or minimizing metastasis in a subject diagnosed with cancer. The compounds of the disclosure are further useful in treating central nervous system diseases (such as, but not limited to, HIV Associated Neurocognitive Disorders (HAND), and/or Alzheimer's disease), pain, inflammation (such as, but not limited to, arthritis), cardiovascular disease (such as, but not limited to, undesired vascular smooth muscle proliferation, atherosclerosis, coronary vascular endothelial dysfunction, and/or coronary artery disease), and/or multiple sclerosis.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: November 26, 2024
    Assignee: Drexel University
    Inventors: Joseph M. Salvino, Xin Feng, Alessandro Fatatis, Fei Shen, Olimpia Meucci
  • Publication number: 20240361747
    Abstract: An automated machining system comprising a CNC machine and a processor configured to automatically identify one or more features to be machined into a workpiece to form a part; determine a set of tools suitable for performing a removal operation associated with machining each feature; identify those tools necessary for performing roughing and finishing removal operations for each feature; generate various sequences of removal operations suitable for machining all of the one or more features; calculate a cost of performing each removal operation sequence; determine which of the removal operations sequences is optimal; generate corresponding toolpaths for machining the features into the workpiece; and provide instructions to the CNC machine for automatically implementing the optimal removal operation sequence and corresponding toolpaths to machine the features into the workpiece to form the part. A system for automatic generation and optimization of machining strategies.
    Type: Application
    Filed: April 26, 2024
    Publication date: October 31, 2024
    Inventors: Justin S. Gray, Fei Shen, Charles A. Mader, Mark A. Powell
  • Patent number: 12077585
    Abstract: Embodiments of the present invention provide isolated proteins comprising antigen binding domains that bind kallikrein related peptidase 2 (hK2), including monospecific and bispecific antibodies. Additional embodiments of the invention provide polynucleotides encoding the hk2-specific proteins, vectors, host cells, and methods of making and using them.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: September 3, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Rajkumar Ganesan, John Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Degang Song, Raymond Brittingham, Sathyadevi Venkataramani, Sanjaya Singh, Yonghong Zhao, Fang Yi, Sherry Lynn La Porte
  • Patent number: 12071466
    Abstract: The present disclosure provides for chimeric antigen receptors (CARs) that specifically target a human Kallikrein-2 (hK2), and immunoresponsive cells comprising such CARs, for the treatment of cancer.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: August 27, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Raymond Brittingham, Rajkumar Ganesan, Sherry La Porte, John T. Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Sanjaya Singh, Degang Song, Sathyadevi Venkataramani, Fang Yi, Yonghong Zhao
  • Publication number: 20240279733
    Abstract: The present disclosure is directed to decoupling library capture (template seeding) from cluster generation to optimise both processes. This is achieved by introducing orthogonality between the seeding and clustering primer.
    Type: Application
    Filed: December 15, 2022
    Publication date: August 22, 2024
    Applicant: Illumina, Inc.
    Inventors: Fei Shen, Mathieu Lessard-Viger, Eric Brustad, Allison Meade, Esteban Armijo, Michael Howard, Jeffrey Fisher, Jonathan Boutell, Ramon Saracho, Olivia Ghazinejad, Seth McDonald, Lena Storms, Jeffrey Brodin
  • Publication number: 20240275159
    Abstract: A method and an apparatus for controlling a shutoff device, and a shutoff device. The shutoff device includes N main switching transistors and N bypass switching transistors. The method includes: controlling the N main switching transistors to be turned on after receiving a heartbeat signal; determining whether a power supply voltage of a processor is less than a first under-voltage protection voltage; and if so, controlling the N main switching transistors to be turned off, and controlling the N bypass switching transistors to be turned on. Thus, N photovoltaic modules and N main switching transistors corresponding to a shutoff device are separated from multiple photovoltaic module groups, so that the photovoltaic module groups corresponding to other shutoff devices can normally output DC voltage to an inverter, and the inverter can normally output AC power for integration into a power grid, thereby ensuring the normal operation of the photovoltaic system.
    Type: Application
    Filed: July 8, 2021
    Publication date: August 15, 2024
    Applicants: ALTENERGY POWER SYSTEM INC., ZHEJIANG INTEPOWER ELECTRONIC CO., LTD.
    Inventors: Dongming ZHOU, Yuhao LUO, Xiao LU, Fei SHEN, Xuan ZHU
  • Publication number: 20240275172
    Abstract: A method and an apparatus for controlling a shutoff device, and a shutoff device. The method is applied to a processor of the shutoff device. The method includes: determining whether a heartbeat signal is received continuously during a first preset period; if so, controlling the N main switching transistors to be turned on, and determining whether the heartbeat signal is not received continuously during a second preset period; and if so, controlling the N main switching transistors to be turned off, and controlling the release circuit to be turned on to release a voltage on the bus. A release circuit is controlled to release voltage on the bus to the ground, thereby rapidly reducing the voltage on the bus, avoiding person danger and safety accidents caused by the long-term presence of the direct current high voltage on the bus, and improving the safety and reliability of a photovoltaic system.
    Type: Application
    Filed: July 8, 2021
    Publication date: August 15, 2024
    Applicant: ALTENERGY POWER SYSTEM INC.
    Inventors: Yuhao LUO, Dongming ZHOU, Fei SHEN, Xuan ZHU, Xiao LU, Guowei MIAO, Wenwei LI
  • Publication number: 20240218082
    Abstract: Provided herein are novel anti-CD28 x anti-PSMA antibodies and methods of using such antibodies for the treatment of PSMA-associated cancers. Subject anti-CD28 x anti-PSMA antibodies are capable of agonistically binding to CD28 costimulatory molecules on T cells and PSMA on tumor cells. Thus, such antibodies selectively enhance anti-tumor activity at tumor sites while minimizing peripheral toxicity. The subject antibodies provided herein are particularly useful in combination with other anti-cancer therapies (e.g., anti-CD3 x anti-PSMA antibodies) for the treatment of prostate cancers.
    Type: Application
    Filed: February 13, 2024
    Publication date: July 4, 2024
    Inventors: John R. Desjarlais, Gregory Moore, Michael Hedvat, Juan Diaz, Veronica Gusti Zeng, Matthew Adam Dragovich, Joseph Erhardt, Theresa McDevitt, Fouad Moussa, Pankaj Seth, Fei Shen, Adam Zwolak
  • Publication number: 20240209419
    Abstract: Methods for on-flow cell selective capture and enrichment of clustered beads, general capture strategies on bead mobility on flow cell surfaces, sorting clustered and unclustered beads, and flow cell reusability for bead immobilization onto flow cells.
    Type: Application
    Filed: December 14, 2023
    Publication date: June 27, 2024
    Applicant: Illumina, Inc.
    Inventors: Naneki McCallum, Fei Shen, Xiaoyu Ma, Weixian Xi, Olivia Ghazinejad, Jeffrey Brodin, Jeff Fisher
  • Publication number: 20240124583
    Abstract: Embodiments of the present invention provide isolated proteins comprising antigen binding domains that bind kallikrein related peptidase 2 (hK2), including monospecific and bispecific antibodies. Additional embodiments of the invention provide polynucleotides encoding the hk2-specific proteins, vectors, host cells, and methods of making and using them.
    Type: Application
    Filed: December 27, 2023
    Publication date: April 18, 2024
    Inventors: Rajkumar Ganesan, John Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Degang Song, Raymond Brittingham, Sathyadevi Venkataramani, Sanjaya Singh, Yonghong Zhao, Fang Yi, Sherry Lynn LaPorte
  • Patent number: 11960423
    Abstract: A PCIe controller and a loopback path using the PCIe controller. The PCIe controller includes: a transport layer transmission module, a transport layer reception module, a memory access module, and a memory, wherein the transport layer transmission module includes a first loopback control module, the transport layer reception module includes a second loopback control module, and the first loopback control module is coupled to the second loopback control module; the memory access module is coupled to the transport layer transmission module and the transport layer reception module, and the memory access module is also coupled to the memory.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: April 16, 2024
    Assignee: CHENGDU STARBLAZE TECHNOLOGY CO., LTD.
    Inventor: Fei Shen